A p105-based Inhibitor Broadly Represses NF-κB Activities

This publication has 56 references indexed in Scilit:

• NF-κB in cancer: a marked target
  Seminars in Cancer Biology, 2003
• Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer
  Cancer Letters, 2002
• NF-κB in cancer: from innocent bystander to major culprit
  Nature Reviews Cancer, 2002
• NF-κB at the crossroads of life and death
  Nature Immunology, 2002
• Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
  Science, 2001
• Aberrant rel/nfkb genes and activity in human cancer
  Oncogene, 1999
• Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
  Nature Medicine, 1999
• TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
  Science, 1996
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• NF-κB Controls Expression of Inhibitor IκBα: Evidence for an Inducible Autoregulatory Pathway
  Science, 1993